CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-02 | Hoge Elizabeth 10% owner | Option exercise | +758,001 | 5,313,261 | ||
| 2026-04-02 | Hoge Elizabeth 10% owner | Option exercise · Series A Non-Voting Convertible Preferred Stock | −22,740.03 | 33,662.22 | ||
| 2026-04-02 | Kalayoglu Murat 10% owner | Option exercise | +758,001 | 5,313,261 | ||
| 2026-04-02 | Kalayoglu Murat 10% owner | Option exercise · Series A Non-Voting Convertible Preferred Stock | −22,740.03 | 33,662.22 | ||
| 2026-03-13 | Singer Michael Director | Gift | −6,555 | 49,578 | ||
| 2026-01-06 | Brunn Carsten President and CEO | Sale | −23,766 | $6.82 | $162K | 323,530 |
| 2026-01-06 | Miljkovic Milos Chief Medical Officer | Sale | −3,573 | $6.82 | $24K | 58,820 |
| 2026-01-06 | Davis Blaine Chief Financial Officer | Sale | −10,591 | $6.82 | $72K | 121,220 |
| 2026-01-02 | DeSilva Nishan M Director | Grant or award | +2,600 | 11,366 | ||
| 2026-01-02 | DeSilva Nishan M Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2026-01-02 | Brunn Carsten President and CEO | Grant or award | +143,200 | 347,296 | ||
| 2026-01-02 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +415,700 | 415,700 | ||
| 2026-01-02 | Malik Kemal Director | Grant or award | +2,600 | 11,133 | ||
| 2026-01-02 | Malik Kemal Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2026-01-02 | Miljkovic Milos Chief Medical Officer | Grant or award | +27,000 | 62,393 | ||
| 2026-01-02 | Miljkovic Milos Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +77,000 | 77,000 | ||
| 2026-01-02 | ZENNER PATRICK J Director | Grant or award | +2,600 | 12,974 | ||
| 2026-01-02 | ZENNER PATRICK J Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2026-01-02 | Seymour June Ann Chief Accounting Officer | Grant or award | +6,500 | 6,500 | ||
| 2026-01-02 | Seymour June Ann Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +19,000 | 19,000 |
Page 1 of 16 · 316 trades